Leon F Massuger

No ORCID on file · 2 papers in corpus
lab-animal 2020
Oncoimmunology ·doi:10.1080/2162402x.2020.1843247

Advanced ovarian cancer (OC) patients have a poor 5-year survival of only 28%, emphasizing the medical need for improved therapies. Adjuvant immunotherapy could be an attractive approach since OC is an immunogenic disease and the presence o…

other 2013
International journal of epidemiology ·doi:10.1093/ije/dyt042

BACKGROUND: Tubal ligation is a protective factor for ovarian cancer, but it is unknown whether this protection extends to all invasive histological subtypes or borderline tumors. We undertook an international collaborative study to examine…